ReviewNaunyn-Schmiedeberg's archives of pharmacology2026

The gut-liver-virus axis in hepatitis B and C: microbiota, immunometabolism, and exosome-mediated therapeutic opportunities.

Kainat Raziq et al.PubMed ↗Publisher ↗

No numbers read from the abstract.